07:13 AM EDT, 10/30/2024 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q3 earnings Wednesday of $6.39 per diluted share, up from $5.38 a year earlier. Analysts polled by Capital IQ expected $6.42. Revenue for the quarter ended Sept. 30 was $748.9 million, compared with $609.4 million a year earlier. Analysts polled by Capital IQ expected $722.8 million. Price:...

Oct 30 (Reuters) - Humana beat Wall Street estimates for third-quarter profit on Wednesday, buoyed by strength in its government-backed Medicare Advantage insurance business for older adults. The health insurer relies heavily on Medicare Advantage plans, through which the U.S. government pays private insurers a fixed rate to manage healthcare for people aged 65 and older or those with disabilities....

Oct 30 (Reuters) - Biogen raised annual profit forecast and beat third-quarter profit expectations on Wednesday, as its cost-cutting measures helped make up for falling sales of its multiple sclerosis medicines. The drugmaker has cut jobs and pulled the plug on less promising drug candidates in a series of cost-saving measures, focusing on higher-growth products as CEO Christopher Viehbacher takes...

06:46 AM EDT, 10/30/2024 (MT Newswires) -- Daqo New Energy ( DQ ) reported on Wednesday a Q3 adjusted loss of $0.59 per diluted American depositary share, swinging from adjusted earnings of $0.59 a year earlier. Two analysts polled by Capital IQ expected adjusted EPS of $0.18. Revenue for the quarter ended Sept. 30 was $198.5 million, down from $484.8...